Analgesics (Pharmacies) - Eastern Africa

Revenue in the Analgesics market is projected to reach US$313.90m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 8.76%, resulting in a market volume of US$477.50m by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$0.68 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in Eastern Africa has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in Eastern Africa have played a crucial role in driving the growth of the Analgesics market. Consumers in this region are increasingly seeking convenience and accessibility when it comes to purchasing healthcare products. As a result, there has been a rising demand for analgesics in pharmacies, which offer a wide range of products and professional advice. Additionally, customers in Eastern Africa are becoming more health-conscious and proactive in managing their well-being, leading to an increased demand for analgesics to alleviate pain and discomfort. Several trends have emerged in the Analgesics market in Eastern Africa that have contributed to its growth. One notable trend is the increasing availability and affordability of generic analgesics. This has made these products more accessible to a larger population, driving up sales in pharmacies. Furthermore, there has been a growing emphasis on natural and herbal remedies in Eastern Africa, leading to a rise in the demand for analgesics derived from natural ingredients. Pharmacies have responded to this trend by stocking a wider range of natural analgesics to cater to the preferences of their customers. Local special circumstances in Eastern Africa have also influenced the development of the Analgesics market. The region has a high prevalence of infectious diseases and chronic conditions, which often result in pain and discomfort for patients. This has created a significant demand for analgesics in pharmacies, as they serve as a convenient and accessible source of relief for individuals suffering from these conditions. Additionally, the growing population and urbanization in Eastern Africa have contributed to the expansion of the pharmacy sector, providing a larger customer base for analgesic products. Underlying macroeconomic factors have also played a role in the growth of the Analgesics market in Eastern Africa. The region has experienced steady economic growth in recent years, leading to an increase in disposable income and purchasing power among consumers. As a result, individuals are more willing and able to spend on healthcare products, including analgesics. Furthermore, advancements in healthcare infrastructure and technology have improved access to pharmacies in Eastern Africa, making it easier for consumers to purchase analgesics. In conclusion, the Analgesics (Pharmacies) market in Eastern Africa has been developing due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing demand for convenience, accessibility, and natural remedies, coupled with the high prevalence of pain-inducing conditions, has driven the growth of the market. Additionally, the region's economic growth and improved healthcare infrastructure have contributed to the expansion of the pharmacy sector.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.